KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Operating Margin: 2010-2024

Historic Operating Margin for Supernus Pharmaceuticals (SUPN) over the last 15 years, with Dec 2024 value amounting to 12.34%.

  • Supernus Pharmaceuticals' Operating Margin fell 5460.00% to -31.35% in Q3 2025 from the same period last year, while for Sep 2025 it was -5.42%, marking a year-over-year decrease of 1451.00%. This contributed to the annual value of 12.34% for FY2024, which is 1321.00% up from last year.
  • Per Supernus Pharmaceuticals' latest filing, its Operating Margin stood at 12.34% for FY2024, which was up 1,522.78% from -0.87% recorded in FY2023.
  • In the past 5 years, Supernus Pharmaceuticals' Operating Margin ranged from a high of 33.38% in FY2020 and a low of -0.87% during FY2023.
  • In the last 3 years, Supernus Pharmaceuticals' Operating Margin had a median value of 6.91% in 2022 and averaged 6.13%.
  • Its Operating Margin has fluctuated over the past 5 years, first crashed by 1,854bps in 2021, then skyrocketed by 1,321bps in 2024.
  • Over the past 5 years, Supernus Pharmaceuticals' Operating Margin (Yearly) stood at 33.38% in 2020, then slumped by 1,854bps to 14.84% in 2021, then crashed by 793bps to 6.91% in 2022, then crashed by 778bps to -0.87% in 2023, then skyrocketed by 1,321bps to 12.34% in 2024.